Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

REPLIGEN CORP Director's Dealing 2024

Mar 19, 2024

30826_dirs_2024-03-19_605ac797-bfee-49b9-a1a2-88fac272575b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2024-03-18

Reporting Person: Pax Margaret (N/A)

More from REPLIGEN CORP

Regulatory Filings 2026
May 15
Interim / Quarterly Report 2026
May 6
Regulatory Filings 2026
May 5
Proxy Solicitation & Information Statement 2026
Apr 27
Annual Report 2026
Apr 2
Proxy Solicitation & Information Statement 2026
Apr 2
Proxy Solicitation & Information Statement 2026
Apr 2
Major Shareholding Notification 2026
Mar 27
Director's Dealing 2026
Mar 23
Director's Dealing 2026
Mar 23
View all filings →